Oxford, United Kingdom
Biotechnology
www.inhibox.com
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
Graham was Professor of Chemistry at the University of Oxford and a leading figure in the field of computer aided drug design and was also the scientific founder of Oxford Molecular Group plc. Graham was awarded the Royal Society Mullard Award for his work on the development of the methods of computer-aided molecular design, their application and exploitation and has been named as the recipient of the American Chemical Society’s Award for computers in chemical and pharmaceutical research.
Graham stepped down from IP Group’s Board in May 2013. Click here to hear Graham talk about his book ‘Spin-Outs’, a guide to and personal history of successfully creating spin-out businesses from university intellectual property. Click here to read about his inclusion in the list of Britain’s top 100 scientists. Graham is also the author of ‘University Intellectual Property: a source of finance and impact’ and ’50 Years at Oxford’.